April 8, 2020

Press release

Ordinary General Meeting

To the shareholders of FluoGuide A/S The board of directors hereby convenes an ordinary general meeting of FluoGuide A/S, CVR no.... [Read more]

March 24, 2020

Press release

FluoGuide is shortlisted for EU grant

COPENHAGEN, Denmark, 24 March 2020 – The European Innovation Council (EIC) has shortlisted 100 companies including FluoGuide for EIC grant. The... [Read more]

March 2, 2020

Press release

FluoGuide A/S’s directed share issue registered at the Danish Business Authority

FluoGuide A/S (“FluoGuide” or “Company”) hereby announces that the directed share issue has been formally registered at the Danish Business Authority... [Read more]

February 27, 2020

Press release

Year-End Report 2019

FluoGuide A/S (“FluoGuide”) today announces its results for the period 1 January– 31 December 2019. The report is available here. Morten... [Read more]

February 17, 2020

Press release

Communiqué from extraordinary general meeting in FluoGuide A/S

FluoGuide A/S (“FluoGuide” or “the Company”) held today an Extraordinary General Meeting (“EGM”). The resolution on a directed issue was resolved.... [Read more]

January 31, 2020

Press release

Extraordinary General Meeting

To the shareholders of FluoGuide A/S Til aktionærerne i FluoGuide A/S (dansk version følger nedenfor) The board of directors hereby convenes... [Read more]

January 29, 2020

Press release

FluoGuide proposes directed share issue to strengthen its ownership and shorten the time to market for FG001

The Board of Directors of FluoGuide A/S (“FluoGuide” or “the Company”) proposes to conduct a directed share issue which can provide... [Read more]

January 15, 2020

Press release

Excellent result of FluoGuide’s FG001 guiding surgical removal of cancer is published

FluoGuide A/S’s (“FluoGuide”) compound FG001 lights up the cancer and its invasive growth and has demonstrated potential to vastly improve the... [Read more]

January 9, 2020

Press release

Safety study initiated with FG001

FluoGuide A/S (“FluoGuide”) hereby announces that the first in vivo dosing of FG001 will commence today. This is an important milestone... [Read more]